Introduction
Based on morphological studies performed in the sixties it was clearly demonstrated that the smooth muscle cell (SMC) is the unique cell type found in medial layer of arteries (reviewed by Wissler in 1968). 1 Simultaneously, Wolinsky and Glagov (1967) 2 showed that SMCs, together with the surrounding extracellular matrix components (elastin and collagen), constitute the contractile unit of the arterial media. It was hence recognized that the SMC is a multifunctional cell; besides its role in arterial contraction, it is also responsible for extracellular matrix component production. At that time, modified SMCs including lipid-laden SMCs, were observed in human and monkey atherosclerotic plaques. It was proposed that the intimal SMCs probably derived from SMCs of the media (Wissler, 1968) . 1 These seminal observations have stimulated decades of research on the role of SMCs in atherosclerosis and other vascular diseases, in particular on the property of SMCs to retain the capacity to shift from a contractile to a synthetic phenotype (for a historical review, see Campbell and Campbell, 2012) . 3 This field of research has expanded considerably by uncovering the importance of, for example, embryonic origin, ectopic progenitor cell origin, arterial localization, and fate of SMCs. A wealth of information is available on the mechanisms responsible for the complex structural and functional changes that SMCs undergo in vascular diseases such as atherosclerosis, restenosis, aneurysms, hypertension, pulmonary hypertension, arterial stiffness, and vascular aging. The aim of this spotlight issue is to bring together a series of papers that gives an update on SMC phenotypic diversity ( Figure 1 ) and highlight recent insights on the underestimated deleterious role of SMCs in several vascular diseases. This issue will also provide an update to the previous Spotlight Issue on 'Smooth Muscle Cells and Vascular Diseases' published 6 years ago in Cardiovascular Research, focusing on exciting novel roles of SMCs while including broader vascular research fields. Each review in this spotlight issue was written by leading basic and translational researchers from different laboratories. As guest editors of this Spotlight Issue, we particularly want to thank all the contributing authors.
Developmental aspects
SMCs and other vascular mural cells such as pericytes have distinct embryonic origins depending on their localization in the vascular tree. This regional heterogeneity could play an essential role in the development of various vascular diseases. After having described the most recent mechanisms including the role of platelet-derived growth factor (PDGF-BB), Notch, and transforming growth factor (TGF)-ß signalling pathways that regulate SMC and pericyte lineages, Sinha and Santoro 4 develop the concept of heterogeneity by building on clinical studies on aneurysms and dissections. Furthermore they highlight recent advances arising from in vitro strategies to derive SMCs from human embryonic stem cells. This strategy enabled the identification of key signalling pathways involved in Marfan syndrome. They also discuss the zebrafish model as a powerful in vivo model to assess vessel development by live imaging. The emerging role of Hox genes in determining the regional vascular susceptibility to atherosclerosis is described in this review, as well as in the review written by Bentzon and Majesky. 5 The embryonic origin, structure, and function of the cerebral vasculature are distinct from that of extracranial vessels. Frösen and Joutel 6 discuss how these features are linked to the development of cerebrovascular diseases such as intracranial arteriovenous malformation, saccular intracranial aneurysms, and small vessel vascular diseases with a particular focus on intracranial SMCs. For example, the roles of vascular endothelial growth factor (VEGF), Notch, and TGF-ß signalling are of particular importance for intracranial vascular development, as evidenced by the observations that mutations in these signalling pathways predispose the brain to arteriovenous malformations through an imbalance between endothelial cell proliferation and recruitment and growth of pericytes and SMCs. can induce vasoconstriction or vasodilation with both physiological and pathophysiological implications. These complex processes that regulate vascular reactivity and the contractile function of SMCs are discussed in several reviews of this Spotlight issue. For example, the myogenic autoregulation responsible for the maintenance of cerebral blood flow despite substantial alterations in systemic blood pressures to adapt to changes in cerebral metabolic demands are highly dependent on vasoconstriction/dilatation. 6 During aging, the regulation of SMC contractility by G-protein coupled receptor (GPCR) signalling pathways is markedly altered. 7 In hypertension, the role of an increased vascular contraction has long been recognized through, for example, the effective antihypertensive actions of L-type calcium channel blockers. Touyz et al. 8 discuss how an abnormal intracellular calcium handling in SMCs may significantly add to hypertension. Besides the classical myogenic response triggered by an increase in intracellular free calcium concentrations, novel findings reveal additional calciumindependent mechanisms as regulators of SMC contraction. In particular, SMC calcium sensitization, through the protein kinase C and RhoA-Rho kinase (ROCK) pathways, may regulate the phosphorylation state of myosin light chain kinase independently of the calcium-calmodulin-complex. These authors also point out that alterations of intracellular calcium concentrations in SMCs not only determine the contractile state but also influence the activity of other calcium-dependent transcription factors and proteins thereby further impacting SMC phenotype and function. the review dedicated to pulmonary hypertension, in which pulmonary arteries undergo remodelling characterized by medial thickening. In experimental animal models, SMC proliferation is transiently observed depending on the stage and the location of the disease. In humans, the importance of SMC proliferation is still an ongoing debate. Because of the muscularization that occurs in small hypertensive pulmonary arteries, SMCs involved in pulmonary hypertension are thought to arise from endothelial cells by a process of endothelial-to-mesenchymal transition (EndMT), from resident or circulating progenitors. Recently the role of inflammation in the progression of the disease has been recognized; SMCs could contribute to this process by acquiring pro-inflammatory properties. Additional SMC alterations include senescence and metabolic changes related to cancer (e.g. increased TGF-b signalling pathway) whose contribution to the pathogenesis of the disease should further be addressed. These new findings will be instrumental to develop appropriate tools for targeting distinct functional SMCs. The signalling pathways implicated in EndMT taking place in several vascular diseases are described in detail in the context of atherosclerosis by Souihol et al. 11 The authors highlight the crucial role of TGF-b signalling which, through canonical TGF-b receptor 2 and non-canonical ALK5 receptor, induces EndMT. Alternatively, NOTCH and Wnt/b-catenin signalling can contribute to EndMT. Disturbed shear stress in atheroprone sites, altered cyclic strain and matrix stiffness, observed in hypertension or aging for example, play a major role in EndMT. Moreover, cardiovascular risk factors facilitate EndMT mainly through oxidative stress and TGF-b signalling.
Origin, fate, and plasticity of SMCs

Vascular weakening and rupture
Degradation of extracellular matrix and loss of SMCs in the aorta contribute to a weakening of the aortic wall, leading to aneurysm formation, which discriminates between abdominal aortic aneurysms being mainly atherothrombotic in origin, thoracic aortic aneurysms associated with mucoid degeneration, and aortic dissections. Michel et al. 12 emphasizes that the thinning and increased permeability of the vascular wall enhance transmural advection of plasma proteins to interact with SMCs and extracellular matrix components in the biomechanical and proteolytic aneurysmal injuries. The epigenetic phenotypic switch of aortic SMCs towards constitutional overexpression and nuclear translocation of Smad2 resulting in an increased anti-protease and extracellular matrix synthesis, further illustrates the importance of SMCs as drivers of aortic aneurysm development and providers of defense mechanisms to prevent aortic rupture, which most commonly is fatal. 12 Pathological saccular dilation may also affect large intracranial arteries, leading to intracranial aneurysm, which typically develops after the age of 40 and to which genetic predisposition, flow conditions and vascular geometry may contribute as pointed out by Frösen and Joutel. 6 Loss of SMCs from the intracranial aneurysmal wall is preceded by lipid accumulation, and may lead to aneurysm rupture and consequently subarachnoid haemorrhage. 6 
SMC stiffening and calcification
Initially considered purely dependent on vascular wall collagen and elastin content, vascular ageing is now recognized as a complex network of molecular and cellular events involving mechanotransduction and inflammation as well as cytoskeleton architectural changes. Lacolley et al. describe how dynamic actin-myosin interactions together with integrin activation in focal adhesion stress fiber complexes may increase the intrinsic SMC stiffness, and how an increased vascular stiffness may hence reflect both alterations of extracellular matrix and a direct increased SMC stiffness. Another cardinal sign of vascular aging is calcification and also in this area, the paradigm has changed from initially being considered a passive deposition of calcium phosphates in the vascular wall to what is now recognized as an active process largely extent orchestrated by SMCs. The loss of SMC markers and gain of osteochondrogenic markers is accompanied by the development of calcifying vesicles, downregulation of calcification inhibitors and synthesis of a calcification prone matrix, which is developed further in the review by Durham et al. 13 
SMC migration, proliferation, and death
The classical clinical implications of SMC migration and proliferation have long been applicable to restenosis after for example percutaneous coronary interventions (PCI). However, based on the discovery that cyclosporin prevents restenosis in a rat model of balloon-catheter injury, the introduction of immunosuppressants in the form of drug-eluting stents has largely reduced the risk of restenosis after PCI.
14 Nevertheless, a significant proportion of patients undergo coronary artery bypass grafting (CABG), which may suffer from failure rate due to intimal thickening in the venous graft following. In the review by Wadey et al., 15 it is further explored how injury to the vessel wall during vein grafting leads to extracellular matrix remodelling, alteration of cell-cell contacts by means of for example cadherins, and increased Wnt/b-catenin signalling, which all contribute to the stimulation of SMC migration and proliferation. Another key regulation of SMC migration and proliferation is constituted by the microRNA family. MicroRNA molecules, which act as regulators of SMC gene expression, have been widely acknowledged in the past and has led to the development of microRNA inhibitors towards clinical trials. 16 More recently, longer non-coding single-stranded RNA species has more recently gained considerable interest as regulators of SMC function such as SMC migration, proliferation, apoptosis and extracellular matrix synthesis, which is developed in detail by Leeper and Maegdefessel. 16 Whereas accumulation of SMCs in the fibrous cap of atherosclerotic plaques is beneficial, loss of SMCs yields fibrous cap weakening and eventually plaque rupture. The mechanisms underlying SMC death in atherosclerosis are discussed by Grootaert et al. 17 In this review, the authors systematically address the causes and consequences of cell apoptosis, necrosis, autophagy, and senescence. SMCs exposed to various stimuli, including reactive oxygen species, oxidized lipids, and inflammatory cytokines, undergo either apoptosis or necrosis resulting in plaque instability. Although its role is still under debate, autophagy, which is related to SMC proliferation and dedifferentiation, is seen as protective by promoting SMC survival. Conversely reduced autophagy leads to vascular aging. A possible detrimental role of autophagy is under debate. Recently, by using genetically-modified mice, it has been shown that defective autophagy induces senescence and cell death, leading to plaque vulnerability. Telomere shortening/uncapping and premature senescence induced by DNA damaging or oxidative stress in SMCs are likely responsible for atherosclerotic plaque instability. The authors emphasize the possibility to use pharmacological products modulating these processes with the aim of preventing plaque rupture.
Conclusion
In conclusion, the authors in this Spotlight 
